Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S4DV
|
||||
| Former ID |
DNC014836
|
||||
| Drug Name |
CALYSTEGINE B2
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H13NO4
|
||||
| Canonical SMILES |
C1CC2(C(C(C(C1N2)O)O)O)O
|
||||
| InChI |
1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m1/s1
|
||||
| InChIKey |
FXFBVZOJVHCEDO-IBISWUOJSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-galactosidase A | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Galactose metabolism | ||||
| Glycerolipid metabolism | |||||
| Sphingolipid metabolism | |||||
| Glycosphingolipid biosynthesis - globo series | |||||
| Lysosome | |||||
| PathWhiz Pathway | Sphingolipid Metabolism | ||||
| Galactose Metabolism | |||||
| Reactome | Glycosphingolipid metabolism | ||||
| WikiPathways | Sphingolipid metabolism | ||||
| References | |||||
| REF 1 | Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.